that's funny ...
there is just as many people saying its associated with removal of calcium ... which is it ?? Perhaps neither
My vote is that its neither.
Much is written on stuff that is weakly linked ... it gives researchers a budget.
The blog you linked to bases its views on the following single reference to the subject
http://www.ncbi.nlm.nih.gov/pubmed/21775389
METHODS AND RESULTS:
A prospective coronary calcium scan was performed in 157 AF patients without significant cardiovascular disease (108 males; mean age 57 ± 9 years). A total of 71 (45%) patients were chronic VKA users. The duration of VKA treatment varied between 6 and 143 months (mean 46 months). No significant differences in clinical characteristics were found between patients on VKA treatment and non-anticoagulated patients. However, median coronary artery calcium scores differed significantly between patients without and patients with VKA treatment [0, inter-quartile range (IQR) 0-40, vs. 29, IQR 0-184; P = 0.001]. Mean coronary calcium scores increased with the duration of VKA use (no VKA: 53 ± 115, 6-60 months on VKA: 90 ± 167, and >60 months on VKA: 236 ± 278; P < 0.001). Multivariable logistic regression analysis revealed that age and VKA treatment were significantly related to increased coronary calcium score.
So, of the 157 patients (of which we know bugger all about) only 45% were long term warfarin users (chronic VKA) ... hardly conclusive if you ask me. I notice that they determine AGE and VKA are significant factors.
But hey, lets ignore age and go for the enemy warfarin ...
For balance I suggest you read this link to a 2010 study:
http://onlinelibrary.wiley.com/doi/1.../clc.20865/pdf
In a cross-sectional analysis of 70 patients (46 men, mean age 68 ± 13 years) on warfarin therapy without known coronary artery disease, after adjustment for cardiovascular risk factors, no correlation between warfarin duration and coronary artery calcification ...
...
These preliminary studies do suggest an association of warfarin use with calcification, but the potential relationship warrants larger prospective randomized studies to better evaluate this relationship. Based on the available data, we do not currently recommend screening for vascular calcification before initiation of warfarin therapy. It is still unclear whether warfarin-associated calcification isclinically significant enough to affect the morbidity and mortality associated with vascular and valvular calcification
so basically they are of the view that its so insignificant its not even worth screening patients.
IMO crossing the road is more dangerous
Of note they seems to mention dabigatran a lot as a potential alternative (which it isn't) and since that costs a LOT more I'd wonder if there is a "
skeleton in the closet" hunt to scare up business for the alternatives (like dabigatran which makes more profit).
In their abstract they say:
Newer anticoagulants such as dabigatran and rivaroxaban offer promise as future therapeutic options in such cases
but in their summary they also say (I'll bold what jumped out at me):
Warfarin still remains the least expensive and most widely available mode of anticoagulation with long-term expertise in managing it, and inexpensive testing for monitoring the dose. It has a proven benefit in preventing strokes in AF patients, recurrent deep venous thrombosis and pulmonary embolism, and in reducing mortality in patient populations at risk for thromboembolic disease. Warfarin is also fairly quickly reversible in case of bleeding and can be safely used in patients with low creatinine clearance. However, the use of warfarin has always been difficult because of complex pharmacodynamics, a narrow therapeutic window, numerous drug-drug and drug-food interactions, and multiple adverse effects.
I love the "difficult" ... because of dipstick clinics just wanting a quick money grab for a simple task of monitoring which they usually cock-up
Then in this study that finds a link:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517807/
In their methods they admit to overdosing the rats
[FONT="] Ten rats were treated daily with a subcutaneous injection of sodium warfarin (100 mg/kg) [/FONT]
so, as I weigh 75Kg if they were dosing me they'd have give me 7000mg of warfarin ... naturally I'd die.
so would the rats ... if they hadn't also done:
[FONT="]and 10 mg/kg vitamin K1[/FONT]
so they gave them what would have been a lethal dose if not for the administration of an antidote to prevent them dying ...
they then observe:
Rationale for the animal model
[FONT="]The animal model used in this study is not completely analogous to the human receiving warfarin. Ideally we would have treated the rats with warfarin on its own to cause an increased clotting time as occurs in the human. However, it is difficult to maintain rats on a therapeutic dose of warfarin due to coprophagia which results in unpredictable dosing. [/FONT]
got to love
coprophagia (and I'm not clear if its the rats or the research model that's eating ****)
meaning "we gave them too much, but we couldn't be bothered in administering such small amounts. OR perhaps "we didn't see any effect till we gave them 10 times a lethal dose + an antidote to the poision"
Also, you'll note us valvers are ignored ... meaning they're after a bigger market ... I'll stay with warfarin thanks.